Seamless Trial Management Across All Phases
Executing Phase II through Phase IV clinical studies requires seamless alignment between investigators, trial monitors, and data managers. Nexiora Lifesciences provides complete operational governance to ensure timelines are met without sacrificing subject safety or data integrity.
Key Execution Capabilities
Protocol Feasibility & Site Activation
Detailed epidemiological study feasibility, investigator selection, and rapid site initiation visits (SIV).
Investigational Product (IP) Management
Temperature-controlled storage monitoring, IP accountability logs, reconciliation, and destruction tracking.
Pharmacovigilance, AE & SAE Management
24/7 Serious Adverse Event (SAE) tracking, medical monitor liaison, and regulatory reporting within mandated timelines.
Quality Promise
100% ICH-GCP E6 (R3) compliance, transparent monitoring visit reports, and audit-ready master trial files throughout the study life cycle.
Request Proposal
Send your protocol outline for trial operational feasibility.